Table 2.
Counterregulatory hormone levels before and during the clamping procedure
Healthy‐euglycaemia | Healthy‐hypoglycaemia | T2D‐hypoglycaemia | ||||
---|---|---|---|---|---|---|
Before | During | Before | During | Before | During | |
Growth hormone (mE/L) | 8.5 ± 4.0 | 0.4 ± 0.2 | 19.1 ± 7.7 | 18.1 ± 7.3 | 3.1 ± 1.7 | 25.7 ± 9.4* |
Cortisol (µmol/L) | 0.38 ± 0.04 | 0.25 ± 0.03 | 0.57 ± 0.18 | 0.53 ± 0.13 | 0.22 ± 0.02 | 0.47 ± 0.07* |
Epinephrine (nmol/L) | 0.12 ± 0.02 | 0.11 ± 0.02 | 0.15 ± 0.04 | 1.15 ± 0.25* | 0.13 ± 0.03 | 1.69 ± 0.74* |
Norepinephrine (nmol/L) | 1.16 ± 0.10 | 1.19 ± 0.17 | 0.94 ± 0.13 | 1.24 ± 0.10* | 1.28 ± 0.13 | 1.90 ± 0.26* |
Data are shown as mean ± SD
P < 0.05 vs before values by Wilcoxon signed rank test.